Medicofarma Biotech

Medicofarma Biotech P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Medicofarma Biotech (MDB.WA) as of Oct 16, 2026 is -34.56. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was -33.34 — a change of 3.65% (lower).

P/FCF

-34.56

YoY

3.65%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Medicofarma Biotech is 2025 -34.56 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Medicofarma Biotech was 2024 -33.34 . It decreases by 3.65% lower compared to the previous year.

The Medicofarma Biotech P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2018
-1,699.46 PLN
Jan 1, 2019
-89.45 PLN
Jan 1, 2020
-109.64 PLN
Jan 1, 2021
-70.81 PLN
Jan 1, 2022
-137.13 PLN
Jan 1, 2023
-30.93 PLN
Jan 1, 2024
-33.34 PLN
Jan 1, 2025
-34.56 PLN
The Medicofarma Biotech P/FCF history
YEARP/FCFYoY
-34.56+3.65%
-33.34+7.80%
-30.93-77.45%
-137.13+93.66%
-70.81-35.42%
-109.64+22.58%
-89.45-94.74%
-1,699.46-350.00%
679.78-140.00%
-1,699.46—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Medicofarma Biotech Stock analysis

What does Medicofarma Biotech do? Medicofarma Biotech SA is a biotechnology company based in Warsaw, Poland. The company is listed on the Warsaw Stock Exchange under the ticker MDB.WA and has an ISIN code of PLINBOK00010. It operates within the Health Care sector, specifically in the Life Sciences Tools & Services industry. Medicofarma Biotech SA completed its initial public offering (IPO) on November 27, 2008. The company focuses on the development and production of innovative medicines, medicinal products, and biotechnology products. Its research and development activities are conducted in laboratories located in Lublin and Poznan, Poland. The company's headquarters are situated in Warsaw, within the Mazowieckie region. Medicofarma Biotech SA's website is https://medicofarmabiotech.pl/. The company is engaged in the development of drugs, medical devices, and biotechnological products. It operates as a public company with a presence in multiple cities across Poland, including Warsaw, Lublin, and Poznan. The company's primary activities involve the research, development, and commercialization of biotechnology-based solutions for the healthcare sector. Medicofarma Biotech SA is registered in Poland and serves the broader European market with its products and services. Medicofarma Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medicofarma Biotech stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Medicofarma Biotech is -34.56 in 2025.

P/FCF (Price-to-Free-Cash-Flow Ratio) of Medicofarma Biotech changed from -33.34 to -34.56, representing a 3.65% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) Medicofarma Biotech since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s Medicofarma Biotech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Medicofarma Biotech

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Medicofarma Biotech